期刊文献+

胃癌根治术后腹腔感染的危险因素分析 被引量:17

Multivariate analysis of risk factors for intra-abdominal infections after radical gastrectomy forgastric cancer
原文传递
导出
摘要 目的探讨胃癌根治术后腹腔感染的主要危险因素。方法采用病例对照分析的方法,回顾性收集湖南省肿瘤医院2010年10月至2013年1月行胃癌根治术的479例胃癌患者的病例资料。根据术后是否出现腹腔感染分为腹腔感染组32例(6.68%)和对照组447例(93.32%)。对两组患者年龄、性别、是否存在合并症、手术时间、手术出血量及术后病理分期等临床病理资料进行Logistic回归分析。结果与对照组相比,腹腔感染组年龄较大、术前淋巴细胞计数较低、术前血红蛋白水平较低、术前白蛋白水平较低,而且手术时间较长[(59±10)比(53±11)岁,(1.4±0.7)×10^9/L比(1.7±0.6)×10^9/L,(108±28)比(117±24)g/L,(34±6)比(37±5)g/L,(244±43)比(216±45)min,均P〈0.05]。单因素分析发现既往有腹部手术史、体质指数〉25kg/㎡、术前存在合并症、糖尿病、胃癌并发症、淋巴细胞计数〈1.5×10^9/L、术前血红蛋白〈100g/L、术前白蛋白〈30∥L、腹水、围术期输血、全胃切除、联合脏器切除和手术时间〉240min13个因素与胃癌根治术后腹腔感染的发生相关(均P〈0.05);进一步行多因素分析显示,其中联合脏器切除(OR=3.64,95%CI:1.39—9.55),体质指数〉25kg/㎡(OR=3.04,95%CI:1.17~7.92),糖尿病(OR=3.41,95%CI:1.05~11.09)和围术期输血(OR=2.24,95%CI:1.02—5.13)是胃癌根治术后腹腔感染的独立危险因素。结论针对胃癌根治术后腹腔感染发生的上述主要影响因素进行干预或许可以降低术后腹腔感染的发生率,从而缩短住院时间并提高生存率。 Objective To explore the major risk factors for intra-abdominal infections after radical gastrectomy in patients with gastric cancer. Methods From October 2010 to January 2013, a total of 479 patients undergoing radical gastrectomy at Department of Gastric, Duodenal & Pancreatic Surgery, Hunan Provincial Tumor Hospital were divided into 2 groups according to an onset of postoperative intra-abdominal infections ( n = 32, 6. 68% ) or not ( n = 447, 93.32% ). Their clinicopathological data, such as age, gender, eo-morbidities, surgical duration, operative blood loss and pathological stage were retrospectively analyzed by Logistic regressive analysis with a case-control study model. Results As compared with the control group, the patients had a greater age ( (59 ± 10) vs (53 ±11 ) years, P 〈0. 01 ) , lower lymphocyte count ( ( 1.4± 0. 7) x 109/L vs ( 1.7 ± 0. 6) x 109/L, P = 0.02), lower hemoglobin level ( ( 108 ±28) vs ( 117 ±24) g/L, P = 0. 04), lower albumin level ( ( 34 ±6 ) vs ( 37 ± 5 ) g/L, P 〈 0. 01 ) and longer surgical duration ( (244 ±243) vs (216± 245) min, P 〈0. 01 ) in the postoperative intra-abdominal infection group. Univariate Logistic regressive analysis found that a history of abdominal surgery, body mass index (BMI) 〉 25 kg/m2, co-morbidities, diabetes mellitus, complications due to gastric cancer, lymphocyte count 〈 1.5 × 109/L, hemoglobin 〈 100 g/L, albumin 〈 30 g/L, ascites, perioperative transfusion, total mastectomy, combined organ resection and surgical duration 〉 240 min were associated with the occurrence of postoperative intra-abdominal infections (all P 〈 0. 05 ) . Further multivariate analysis identified 4 independent risk factors for intra-abdominal infections after radical gastrectomy, including combined multiorgan resection ( OR = 3.64, 95% CI: 1.39 - 9. 55), BMI 〉 25 kg,/m2 ( OR = 3.04, 95% CI: 1. 17 -7.92), diabetes mellitus ( OR = 3.41, 95 % CI: 1.05 - 11.09) and perioperative transfusion ( OR = 2. 24, 95% CI: 1.02 - 5.13). Conclusion A correction of modifiable risk factors may reduce the incidence of intra-abdominal infections after radical gastrectomy, shorten the length of hospital stays and improve outcomes in patients with gastric cancer.
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第40期3211-3214,共4页 National Medical Journal of China
关键词 胃肿瘤 外科手术 危险因素 腹腔感染 Stomach neoplasms Surgical procedures, operative Risk factors Intra-abdominal infection
  • 相关文献

参考文献13

  • 1Sugisawa N, Tokunaga M, Tanizawa Y, et al. Intra-abdominal infectious complications following gastrectomy in patients with excessive visceral fat. Gastric Cancer, 2012, 15:206-212.
  • 2Kwon SJ. Evaluation of the 7th UICC TNM Staging System of Gastric Cancer. J Gastric Cancer, 2011, 11:78-85.
  • 3Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer, 2011, 14: 113-123.
  • 4Lo CH, Chen JH, Wu CW, et al. Risk factors and management of intra-abdominal infection after extended radical gastrectomy. Am J Surg, 2008, 196: 741-745.
  • 5Sah BK, Zhu ZG, Chen MM, et al. Gastric cancer surgery and its hazards: post operative infection is the most important complication. Hepatorastroentemlogv, 2008, 55:2259-2263.
  • 6陈士远,周岩冰,王浩,李世宽,毛伟征,王海波.胃癌切除术后腹腔感染的影响因素[J].中华胃肠外科杂志,2009,12(2):137-140. 被引量:14
  • 7Tokunaga M, Tanizawa Y, Bando E, et al. Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer. Ann Surg Oncol, 2013, 20:1575-1583.
  • 8Sierzega M, Kolodziejczyk P, Kulq J, et al. Impact of anastomotic leakage on long-term survival after total gastrectomy for carcinoma of the stomach. Br J Surg, 2010, 97 : 1035-1042.
  • 9吴晖,徐萍萍,何裕隆,徐建波,蔡世荣,张信华,王亮,杨东杰,詹文华.胃癌手术方式对患者手术创伤程度的影响[J].中华医学杂志,2012,92(38):2694-2698. 被引量:12
  • 10Hirao M, Tsujinaka T, Imamura H, et al. Overweight is a risk factor for surgical site infection following distal gastrectomy for gastric cancer. Gastric Cancer, 2013, 16:239-244.

二级参考文献20

  • 1Burke JP. Infection control-a problem for patient safety. N Engl J Med, 2003, 348(7) :651-656.
  • 2Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma-2nd Ed. Gastric Cancer, 1998, 1 (1):10-24.
  • 3Wittmann DH. Intraabdominal infections-introduction. World J Surg, 1990, 14(2) : 145-147.
  • 4Pacelli F, Doglietto GB, Alfieri S, et al. Prognosis in intraabdominal infections. Multivariate analysis on 604 patients. Arch Surg, 1996,131 (6) : 641-645.
  • 5Pieracci FM, Barie PS. Intra-abdominal infections. Curr Opin Crit Care, 2007,13(4) :440-449.
  • 6Japanese Gastric Cancer Association. Japanese gastric cancertreatment guidelines 2010 (ver. 3). Gastric Cancer, 2011,14:113-123.
  • 7Sasako M. Gastric cancer eastern experience. Surg Oncol Clin NAm,2012, 21:71-77.
  • 8Mita K, Ito H, Fukumoto M,et al. Surgical outcomes andsurvival after extended multiorgan resection for T4 gastric cancer.Am J Surg, 2012,203: 107-111.
  • 9Deng J, Liang H, Sun D, et al. Extended lymphadenectomyimprovement of overall survival of gastric cancer patients withperigastric node metastasis. Langenbecks Arch Surg, 2011,396:615-623.
  • 10Songun I,Putter H, Kranenbarg EM, et al. Surgical treatment ofgastric cancer : 15-year follow-up results of the randomisednationwide Dutch Dl D2 trial. Lancet Oncol,2010,11 :439-449.

共引文献24

同被引文献184

引证文献17

二级引证文献152

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部